Delhi Pharmaceutical Sciences and Research University

According to Unofficial sources, the sector-wise DPSRU alumni placement statistics is presented below:

Note: The “Others” category includes the sectors of Business Development, Marketing, Community & Social Service, Median & Communication, Sales, IT, HR, Administrative, Consulting, Customer Success & Support and Legal.

The above-mentioned data is gathered from unofficial sources, hence may vary.

As per Delhi Pharmaceutical Sciences and Research University Annual Report 2023, the the highest and average package offered during MBA/MPH/MSc/MHM placements 2023 stood at INR 15 LPA and INR 5.67 LPA, respectively.

The highest and average package offered during DPSRU MPharm placements 2023 stood at INR 15 LPA and INR 6.84 LPA, respectively. Further, according to Pharmacy NIRF report 2024, the key highlights of DPSRU MPharm placements over the past three years are presented below:

According to Pharmacy NIRF report 2024, the key highlights of DPSRU BPharm placements over the past three years are presented below:

The department-wise number of students placed during DPSRU placements 2023 is presented below:

The highest package offered during DPSRU placements 2023 is presented below:

According to Pharmacy NIRF report 2024, the median package offered during DPSRU BPharm and MPharm placements over the past three years are presented below:

The average package for MPharma at Delhi Pharmaceutical Sciences and Research University was between INR 5 LPA and INR 6.5 LPA. The table given below presents the same:

Delhi Pharmaceutical Sciences and Research University has released its placement highlights for 2025. The table below provides the placement statistics as per the official data released by the college:

The four-year BPharm programme at Delhi Pharmaceutical Sciences and Research University is broken up into eight semesters. At the undergraduate level, the university provides BPharm General and BPharm Ayurved. In addition, the university provides lateral admission into its BPharm program. Applicants for BPharm must have finished Class 12 with at least a 55% aggregate in PCM or PCB subjects.